» Articles » PMID: 32066828

Structural and Functional Imaging Markers for Susceptibility to Psychosis

Overview
Journal Mol Psychiatry
Date 2020 Feb 19
PMID 32066828
Citations 37
Authors
Affiliations
Soon will be listed here.
Abstract

The introduction of clinical criteria for the operationalization of psychosis high risk provided a basis for early detection and treatment of vulnerable individuals. However, about two-thirds of people meeting clinical high-risk (CHR) criteria will never develop a psychotic disorder. In the effort to increase prognostic precision, structural and functional neuroimaging have received growing attention as a potentially useful resource in the prediction of psychotic transition in CHR patients. The present review summarizes current research on neuroimaging biomarkers in the CHR state, with a particular focus on their prognostic utility and limitations. Large, multimodal/multicenter studies are warranted to address issues important for clinical applicability such as generalizability and replicability, standardization of clinical definitions and neuroimaging methods, and consideration of contextual factors (e.g., age, comorbidity).

Citing Articles

Size and Topography of the Brain's Functional Networks with Psychotic Experiences, Schizophrenia, and Bipolar Disorder.

Mamah D, Chen S, Gordon E, Kandala S, Barch D, Harms M Biol Psychiatry Glob Open Sci. 2025; 4(6):100386.

PMID: 39829963 PMC: 11740805. DOI: 10.1016/j.bpsgos.2024.100386.


How will developmental neuroimaging contribute to the prediction of neurodevelopmental or psychiatric disorders? Challenges and opportunities.

Perez-Edgar K, Dozier M, Saxe R, MacDuffie K Dev Cogn Neurosci. 2024; 71():101490.

PMID: 39700912 PMC: 11721882. DOI: 10.1016/j.dcn.2024.101490.


Schizophrenia Detection and Classification: A Systematic Review of the Last Decade.

Saha A, Park S, Geem Z, Singh P Diagnostics (Basel). 2024; 14(23).

PMID: 39682605 PMC: 11640697. DOI: 10.3390/diagnostics14232698.


Revisiting the role of computational neuroimaging in the era of integrative neuroscience.

Loosen A, Kato A, Gu X Neuropsychopharmacology. 2024; 50(1):103-113.

PMID: 39242921 PMC: 11525590. DOI: 10.1038/s41386-024-01946-8.


Intermittent Theta Burst Stimulation Combined with Cognitive Training to Improve Negative Symptoms and Cognitive Impairment in Schizophrenia: A Pilot Study.

Vergallito A, Gesi C, Torriero S Brain Sci. 2024; 14(7).

PMID: 39061423 PMC: 11274516. DOI: 10.3390/brainsci14070683.


References
1.
Ramyead A, Studerus E, Kometer M, Uttinger M, Gschwandtner U, Fuhr P . Prediction of psychosis using neural oscillations and machine learning in neuroleptic-naïve at-risk patients. World J Biol Psychiatry. 2015; 17(4):285-95. DOI: 10.3109/15622975.2015.1083614. View

2.
Fusar-Poli P, Broome M, Woolley J, Johns L, Tabraham P, Bramon E . Altered brain function directly related to structural abnormalities in people at ultra high risk of psychosis: longitudinal VBM-fMRI study. J Psychiatr Res. 2010; 45(2):190-8. DOI: 10.1016/j.jpsychires.2010.05.012. View

3.
Fusar-Poli P, Cappucciati M, Rutigliano G, Lee T, Beverly Q, Bonoldi I . Towards a Standard Psychometric Diagnostic Interview for Subjects at Ultra High Risk of Psychosis: CAARMS versus SIPS. Psychiatry J. 2016; 2016:7146341. PMC: 4904115. DOI: 10.1155/2016/7146341. View

4.
Schultze-Lutter F, Ruhrmann S, Berning J, Maier W, Klosterkotter J . Basic symptoms and ultrahigh risk criteria: symptom development in the initial prodromal state. Schizophr Bull. 2008; 36(1):182-91. PMC: 2800137. DOI: 10.1093/schbul/sbn072. View

5.
Atkinson R, Fulham W, Michie P, Ward P, Todd J, Stain H . Electrophysiological, cognitive and clinical profiles of at-risk mental state: The longitudinal Minds in Transition (MinT) study. PLoS One. 2017; 12(2):e0171657. PMC: 5302824. DOI: 10.1371/journal.pone.0171657. View